Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial | Zendy

Beata Banaszewska | Zendy; Leszek Pawełczyk | Zendy; Robert Spaczyński | Zendy; Antoni J. Dulęba | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial

Author(s) -

Beata Banaszewska,

Leszek Pawełczyk,

Robert Spaczyński,

Antoni J. Dulęba

Publication year - 2009

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2009-1674

Subject(s) - simvastatin , metformin , polycystic ovary , medicine , endocrinology , free androgen index , hyperandrogenism , testosterone (patch) , statin , metabolic syndrome , prospective cohort study , insulin resistance , diabetes mellitus

Polycystic ovary syndrome (PCOS) is characterized by ovarian dysfunction and hyperandrogenism; it is also associated with increased cardiovascular risks such as adverse lipid profile and endothelial dysfunction. Metformin and, more recently, statins have been shown to improve endocrine and metabolic aspects of PCOS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research